Since in insulin resistant conditions insulin is not able to suppress gluconeogenesis, the inhibition of G6pase and PEPCK by BITC might be considered positive in type 2 diabetes prevention and treatment. Here, PCK2 is linked to type 2 diabetes mellitus.